Atropine and pralidoxime and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Atropine and pralidoxime and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: atropine / pralidoxime
Brand name: ATNAA, DuoDote
Synonyms: Atropine and Pralidoxime
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Atropine and pralidoxime-Insulin degludec
- Atropine and pralidoxime-Insulin Degludec (U-100) Prefilled Pens
- Atropine and pralidoxime-Insulin Degludec (U-100) Vials
- Atropine and pralidoxime-Insulin Degludec (U-200) Prefilled Pens
- Atropine and pralidoxime-Insulin degludec and liraglutide
- Atropine and pralidoxime-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Atropine Auto-Injector
- Insulin aspart, recombinant Subcutaneous-Atropine Care Ophthalmic
- Insulin aspart, recombinant Subcutaneous-Atropine Eye Drops
- Insulin aspart, recombinant Subcutaneous-Atropine Eye Ointment
- Insulin aspart, recombinant Subcutaneous-Atropine Eye Ointment Ophthalmic
- Insulin aspart, recombinant Subcutaneous-Atropine injection